Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients

Dominic Chu; Marko Popovic; Edward Chow; David Cella; Jennifer L Beaumont; Henry Lam; Jasmine Nguyen; Julia Di Giovanni; Natalie Pulenzas; Gillian Bedard; Andrew Bottomley

doi:10.2217/cer.14.41

Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients

J Comp Eff Res. 2014 Sep;3(5):523-31. doi: 10.2217/cer.14.41.

Authors

Dominic Chu¹, Marko Popovic, Edward Chow, David Cella, Jennifer L Beaumont, Henry Lam, Jasmine Nguyen, Julia Di Giovanni, Natalie Pulenzas, Gillian Bedard, Andrew Bottomley

Affiliation

¹ Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

PMID: 25350803
DOI: 10.2217/cer.14.41

Abstract

This review aims to compare and contrast the development, characteristics and validity of two widely used quality of life assessment tools in patients with prostate cancers: the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-PR25) and Functional Assessment of Chronic Illness Therapy (FACT-P). Both questionnaires present several strengths as well as some limitations in measuring the quality of life of prostate cancer patients. Each tool may be selected accordingly based on study design and needs.

Keywords: EORTC QLQ-PR25; FACT-P; assessment; prostate cancer; quality of life; questionnaire.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Attitude to Health*
Chronic Disease
Europe
Humans
Internationality
Male
Prostatic Neoplasms / psychology*
Quality of Life / psychology*
Reproducibility of Results
Surveys and Questionnaires / standards*
United States